Unique ID issued by UMIN | UMIN000032670 |
---|---|
Receipt number | R000037254 |
Scientific Title | A study for evaluating the safety of the intake of a test food for healthy adults. |
Date of disclosure of the study information | 2018/05/28 |
Last modified on | 2018/10/29 13:43:13 |
A study for evaluating the safety of the intake of a test food for healthy adults.
A study for evaluating the safety of the intake of a test food.
A study for evaluating the safety of the intake of a test food for healthy adults.
A study for evaluating the safety of the intake of a test food.
Japan |
None
Adult |
Others
NO
To evaluate the safety of excessive (19.5 g ; three times the estimated amount of daily intake) ingestion of a test food for 4 weeks.
Safety
Hematologic test
Blood biochemistry test
Urine analysis
Blood pressure/pulsation
Weight
Doctor's questions
Adverse event
Stool output, defecation frequency, defecation days, fecal condition
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Food |
Ingestion of a test food for 4 weeks
20 | years-old | <= |
64 | years-old | >= |
Male and Female
(1) Healthy males and females aged 20-64 years.
(2) Subjects with a tendency for constipation at around three to five times of defecation per week.
(1) Subjects who routinely use food rich in dietary fiber.
(2) Subjects routinely taking medicine or health food which may influence bowel movement.
(3) Subjects having a large amount of foods which may influence bowel movement such as food containing dietary fiber and lactic acid bacteria.
(4) Subjects visiting the hospital for diseases related bowel movements and using drugs, or using commercial laxative.
(5) Subjects having diseases or a history of drug addiction or alcoholism.
(6) Subjects who are under treatment or have a history of serious disease(e.g., diabetes, liver disease, kidney disease, or heart disease).
(7) Subjects having possibilities for emerging allergy related to the study.
(8) Subjects who are under medication or having a history of serious diseases for which medication was required.
(9) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on preliminary examination.
(10) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study.
(11) Subjects who are planned to become pregnant after informed consent for the current study or are pregnant or lactating.
(12) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire.
(13) Subjects judged as unsuitable for the study by the investigator for other reasons.
20
1st name | |
Middle name | |
Last name | Hiroki Takagi |
NIHON SHOKUHIN KAKO CO., LTD.
RESEARCH INSTITUTE
30 TAJIMA FUJI, SHIZUOKA
0545-53-5995
hiroki.takagi@nisshoku.co.jp
1st name | |
Middle name | |
Last name | Shingo Yamamichi |
TTC Co.,Ltd
Clinical Research Planning Department
Seibu Shinkin Bank Ebisu Bldg.,1-20-2, Ebisunishi, Shibuya-ku, Tokyo
03-5459-5329
s.yamamichi@ttc-tokyo.co.jp
TTC Co.,Ltd
NIHON SHOKUHIN KAKO CO., LTD.
Profit organization
NO
2018 | Year | 05 | Month | 28 | Day |
Unpublished
Completed
2018 | Year | 05 | Month | 10 | Day |
2018 | Year | 05 | Month | 29 | Day |
2018 | Year | 05 | Month | 22 | Day |
2018 | Year | 10 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037254